Modulation of IL-10, IL-12, and IFN-γ in the epidermis of hairless mice by UVA (320-400 nm) and UVB (280-320 nm) radiation

被引:58
作者
Shen, J [1 ]
Bao, S [1 ]
Reeve, VE [1 ]
机构
[1] Univ Sydney, Dept Vet Anat & Pathol, Sydney, NSW 2006, Australia
关键词
cytokine; image analysis; immunohistochemistry;
D O I
10.1046/j.1523-1747.1999.00782.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We have observed recently that the suppression of contact hypersensitivity (CHS) induced in mice by UVB irradiation may be prevented by suberythemal exposure to UVA radiation. Because the UVB-immunosuppressed state is associated with an upregulation of the Th2-associated cytokines IL-10 and IL-4, and a deficiency in Th1-associated IL-2, IL-12, and IFN-gamma, and because UVA photoimmunoprotection appeared to be IFN-gamma- dependent, we tested the hypothesis that UVA immunoprotection results from an ability to prevent the UVB-induced cytokine disarray, This study describes changes in epidermal IL-10, IL-12 and IFN-gamma for 5 d following irradiation of hairless mice with the CHS-modulating doses of UVB, UVA, or UVA + UVB, using immunohistochemical detection in paraffin embedded skin sections, followed by image analysis quantitation, We found that UVB, but not UVA exposure, caused an increase in epidermal IL-10 expression, peaking at 3 d, UVA irradiation, but not UVB, resulted in increased epidermal IL-12 expression, peaking at 3 d, and increased epidermal IFN-gamma expression peaking earlier at 1 d, Irradiation with UVA + UVB abrogated the UVB-enhanced expression of IL-10, and caused small but significant increases in IL-12 and IFN-gamma at 3 d and 1 d, respectively. These findings suggest that UVA photoimmunoprotection is mediated via prevention of IL-10 release, and thus the maintenance of the Th1/Th2 balance, probably by upregulation of IL-12 and IFN-gamma, which are known to antagonize IL-10 in numerous models. The time course suggests that IFN-gamma responds initially to WA radiation, and may stimulate the increased expression of IL-12.
引用
收藏
页码:1059 / 1064
页数:6
相关论文
共 36 条
[1]  
ARAI T, 1995, IMMUNOLOGY, V85, P381
[2]   INTERFERON-GAMMA INHIBITS INTERLEUKIN-10 PRODUCTION BY MONOCYTES [J].
CHOMARAT, P ;
RISSOAN, MC ;
BANCHEREAU, J ;
MIOSSEC, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :523-527
[3]   Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa [J].
Cole, N ;
Bao, SS ;
Willcox, M ;
Husband, AJ .
INFECTION AND IMMUNITY, 1999, 67 (05) :2497-2502
[4]   The role of interleukin-4 in ultraviolet B light-induced immunosuppression [J].
ElGhorr, AA ;
Norval, M .
IMMUNOLOGY, 1997, 92 (01) :26-32
[5]   EARLY INTERLEUKIN-12 PRODUCTION BY MACROPHAGES IN RESPONSE TO MYCOBACTERIAL INFECTION DEPENDS ON INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA [J].
FLESCH, IEA ;
HESS, JH ;
HUANG, S ;
AGUET, M ;
ROTHE, J ;
BLUETHMANN, H ;
KAUFMANN, SHE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1615-1621
[6]   INTERLEUKIN-10 PRODUCTION BY CULTURED HUMAN KERATINOCYTES - REGULATION BY ULTRAVIOLET-B AND ULTRAVIOLET A1 RADIATION [J].
GREWE, M ;
GYUFKO, K ;
KRUTMANN, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (01) :3-6
[7]   Rapid synthesis of IFN-γ by T cells in skin may play a pivotal role in the human skin immune system [J].
Hassan-Zahraee, M ;
Wu, JP ;
Gordon, J .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (11) :1599-1612
[8]   In human skin, UVB initiates early induction of IL-10 over IL-12 preferentially in the expanding dermal monocytic/macrophagic population [J].
Kang, KF ;
Gilliam, AC ;
Chen, GF ;
Tootell, E ;
Cooper, KD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) :31-38
[9]   MODULATION OF INTERFERON-GAMMA-INDUCED HLA-DR EXPRESSION ON THE HUMAN KERATINOCYTE CELL-LINE SCC-13 BY ULTRAVIOLET-RADIATION [J].
KHAN, IU ;
BOEHM, KD ;
ELMETS, CA .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1993, 57 (02) :285-290
[10]   INTERLEUKIN-10 INHIBITS THE ELICITATION PHASE OF ALLERGIC CONTACT HYPERSENSITIVITY [J].
KONDO, S ;
MCKENZIE, RC ;
SAUDER, DN .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (06) :811-814